Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Nursing Ethical Principles II01:27

Nursing Ethical Principles II

Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's cancer...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multidisciplinary clinician perspectives on avoidable emergency department use by patients during cancer treatment.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2025
Same author

FtsK is critical for the assembly of the unique divisome complex of the FtsZ-less <i>Chlamydia trachomatis</i>.

eLife·2025
Same author

How English- and Spanish-preferring patients with cancer decide on emergency care.

The American journal of managed care·2024
Same author

FtsK is Critical for the Assembly of the Unique Divisome Complex of the FtsZ-less <i>Chlamydia trachomatis</i>.

bioRxiv : the preprint server for biology·2024
Same author

Plasticity in the cell division processes of obligate intracellular bacteria.

Frontiers in cellular and infection microbiology·2023
Same author

The Unique N-Terminal Domain of Chlamydial Bactofilin Mediates Its Membrane Localization and Ring-Forming Properties.

Journal of bacteriology·2023

Related Experiment Videos

Understanding and surviving the transition to value-based oncology.

John V Cox1, John D Sprandio, Ronald Barkley

  • 1From Texas Oncology, PA, Dallas, TX; Consultants in Medical Oncology & Hematology, Drexel Hill, PA; Cancer Center Business Development Group, Bedford, NH.

American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|May 30, 2013
PubMed
Summary

The oncology sector must develop innovative business models to ensure sustainable cancer care delivery. This involves creating new value propositions for patients and a resilient healthcare system.

Related Experiment Videos

Area of Science:

  • Oncology business innovation and healthcare management.
  • Development of sustainable healthcare models for cancer care.

Background:

  • The 2012 Cancer Center Business Summit (CCBS) focused on 'Transitioning to Value-Based Oncology: Strategies to Survive and Thrive.'
  • The summit addressed the need for innovative business models in oncology to ensure future sustainability.

Framework:

  • Exploring creative and pioneering business models and practices in oncology.
  • Identifying strategies for a responsible and sustainable platform for cancer care delivery.

Implementation:

  • Focus on forging new business models and relationships within the healthcare sector.
  • Piloting innovative solutions to address the evolving landscape of cancer care.

Implications:

  • Defining a new value proposition for cancer care.
  • Establishing a sustainable healthcare system for the future benefit of patients.
  • Ensuring the responsible and effective delivery of oncology services.